Buy 5paisa Capital Ltd For Target Rs.530 - ICICI Direct
Healthy client accretion; gradual uptick in PAT…
About the stock: 5 Paisa is a leading discount stock broker backed by the Nirmal Jain led IIFL group.
* Aggressive client accretion with ~84% of incremental client from Tier II & below cities and ~78% of customers below 35 years of age
* The company has retail cash market share of 3.6% as of September 2021
Q2FY22 Results: 5 Paisa reported mixed Q2FY22 results.
* ADTO was up 40% QoQ amid robust client accretion at 3.42 lakh
* Revenue was up 13% QoQ to | 68 crore, primarily led by 43% QoQ rise in the MTF book
* Elevated marketing & other expense impacted earnings momentum with PAT at | 1.7 crore (down 77% QoQ)
What should investors do? 5 Paisa’s share price has grown by ~2.4x over the past four years (from ~| 220 in November 2017 to ~| 537 levels in October 2021).
* Being a new age fintech broker, we retain our BUY rating on the stock.
Target Price and Valuation: We value 5 Paisa at ~38x P/E on FY23E EPS to arrive at revised target price of | 530 per share.
Key triggers for future price performance:
* Focus on aggressive client accretion to aid ADTO and thereby topline
* Revamp existing product suite, new product launch, improvement in technology & branding to support incremental accretion
* MTF surge, client addition to aid earnings growth and return ratios
* Elevated marketing & tech spends may lead to gradual uptick in earnings
* Higher client engagement to improve activation is the key ahead
Alternate Stock Idea: Apart from 5 Paisa, in our coverage we also like MCX.
* MCX is a leader in commodity derivative exchanges in India with ~94% market share in commodities future space as on FY21
* BUY with target price of | 2,000
To Read Complete Report & Disclaimer Click Here
https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
Above views are of the author and not of the website kindly read disclaimer